As part of our commitment to providing advanced treatments, we offer insights into how innovative solutions like Semaglutide, a GLP-1 receptor agonist , can support your weight loss journey by reducing appetite and promoting a healthier body composition
Discussion of Table 1: Table 1 synthesizes available data on formulary access for Wegovy (a representative weight-loss GLP-1) under the top PBMs, plus a note on general employer plans
Do not use if tamper-evident seal is broken or missing
Each 0.1 mL drawn in an insulin syringe delivers 200 mcg
According to NICE guidance, GLP-1 receptor agonists are recommended for specific patient groups with type 2 diabetes (NG28) and, in some formulations like Wegovy (semaglutide 2.4mg) and Saxenda (liraglutide 3mg), for weight management in adults with obesity or overweight with weight-related comorbidities
Cong, R., Deng, C., Li, P., Tang, Y., Hou, J., Zhao, J., Wang, Q., Chen, Y., Tu, J., Jiang, X., & Jiang, L